CYTOGEN LAUNCHES SOLTAMOX ORAL LIQUID FOR BREAST CANCER.
Biotech Business › Vol. 19 Nbr. 10, October 2006
Linked as:
Extract
CYTOGEN LAUNCHES SOLTAMOX ORAL LIQUID FOR BREAST CANCER.
Cytogen Corporation, Prineton, N.J. has announced that SOLTAMOX(tm) (tamoxifen citrate, oral solution 10mg/5mL), the first liquid form of the hormonal breast cancer therapy tamoxifen, is currently being introduced in the United States and is available in U.S. pharmacies nat...
See the full content of this document
Sponsored links
